Glaxosmithkline Share News (GSK)

UPDATE 1-Drugmaker GSK to steer Asian business from new Singapore HQ

* 100 job roles to move to Singapore * New HQ slated for completion in late 2016 (Adds details, CEO comments) SINGAPORE/LONDON, March 11 (Reuters) - Drugmaker GlaxoSmithKline will establish a new headquarters for Asia in Singapore to make quicker decisions for the region, a move tha

Drugmaker GSK to steer Asian business from new Singapore HQ

March 11 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it was establishing a new global headquarters for Asia in Singapore, strengthening its presence in the city-state. The British-based group expects its pharmaceutical, consumer healthcare and vaccine businesses to grow signific

Tuesday broker round-up

Pearson: Barclays reiterates equal-weight recommendation and keeps target at 1,405p. UBM: Westhouse Securities takes target to 599p from 552p but reiterates add. ARM Holdings: Citi keeps at buy with a 1,35p target price. Kaz Minerals: Jefferies shaves target to 250p from 275p and reiterates hold.

UK MIDDAY BRIEFING: WPP Profit Growth Meets Hopes

TOP NEWS: Eurogroup Chief Wants More Greek Reform As ECB Starts QE

UK MORNING BRIEFING: WPP Follows Market Down Despite Upbeat Report

PRESS: Glaxo Fires 100 China Staff After Corruption Scandal - FT

GSK sacks 110 China staff in wake of drug bribery case - sources

By Ben Hirschler LONDON, March 6 (Reuters) - Drugmaker GlaxoSmithKline , which was fined 3 billion yuan ($479 million) in China last year for bribery, is dismissing 110 employees in the country for misconduct, people familiar with the matter said on Friday. The British company confirm

Thursday newspaper round-up: BoE, China, North Sea

The Serious Fraud Office has opened a criminal investigation into the Bank of England over the potential rigging of money market auctions. Confirmation of the inquiry came last night with the central bank already under scrutiny over an earlier investigation into the foreign exchange-rigging scandal.

Bristol's $1 bln Bavarian deal may signal cancer vaccine revival

By Ben Hirschler LONDON, March 4 (Reuters) - The idea of using vaccines to fight cancer has received a shot in the arm from a $1 billion deal between Bristol-Myers Squibb and Bavarian Nordic . The agreement gives the U.S. drugmaker an exclusive option to the Danish biotech firm's ther

ANALYST VIEW-Genmab 2014 operating profit above guidance

March 3 (Reuters) - Danish biotech firm Genmab reported 2014 operating income (EBIT) above its own guidance late on Monday. Genmab's operating profit rose to 265 million Danish crowns ($40 million), up from 69 million crowns in 2013. It had previously predicted profits would come in at bet

UK MIDDAY BRIEFING: Tullow Oil Takes New Hit, Set To Drop From FTSE 100

TOP NEWS: UK Manufacturing Activity Hits Seven Month High In February

UPDATE 1-GSK and Novartis complete deals to reshape both drugmakers

(Adds details on drugs, background) By Ben Hirschler LONDON, March 2 (Reuters) - GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers. GSK is forming a consumer health joint venture w

UK MORNING BRIEFING: Intertek Leads Firm Early Market